Use Able AI chat for product recommendations

CD85j / LILRB1 Polyclonal antibody

CD85j / LILRB1 Polyclonal Antibody for WB, IHC, FC (Intra), ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, IHC, FC (Intra), ELISA

LILRB1, CD85, CD85 antigen-like family member J, CD85j, FLJ37515

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for CD85j / LILRB1 in ?

Tested Applications

Positive WB detected inDaudi cells, Ramos cells
Positive IHC detected inhuman liver tissue, human tonsillitis tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive FC (Intra) detected inRamos cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunohistochemistry (IHC)IHC : 1:200-1:800
Flow Cytometry (FC) (INTRA)FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

26455-1-AP targets CD85j / LILRB1 in WB, IHC, FC (Intra), ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag24795

Product name: Recombinant human LILRB1 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 137-241 aa of BC015731

Sequence: SGGNVTLQCDSQVAFDGFILCKEGEDEHPQCLNSQPHARGSSRAIFSVGPVSPSRRWWYRCYAYDSNSPYEWSLPSDLLELLVLGVSKKPSLSVQPGPIVAPEET

Predict reactive species
Full Name leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
Calculated Molecular Weight 71 kDa
Observed Molecular Weight 71 and 110 kDa
GenBank Accession NumberBC015731
Gene Symbol LILRB1
Gene ID (NCBI) 10859
RRIDAB_2880518
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ8NHL6
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

LILRB1, also named as CD85j or ILT2, includes four C2 Ig domains binding HLA class I molecules in the extracellular region and a cytoplasmic domain containing four immunoreceptor tyrosine-based inhibition motifs (ITIM). LILRB1 is a surface glycoprotein detected on the surface of B cells, monocytes, dendritic cells, T cells and NK cells. The predicted MW of LILRB1 is 71 kDa and 26455-1-AP antibody recognizes the 71 and 110 kDa which might be the noncovalently linked monomer. (PMID:17601702; 15474475; 17549736; 24098421)

Protocols

Product Specific Protocols
FC protocol for CD85j / LILRB1 antibody 26455-1-APDownload protocol
IHC protocol for CD85j / LILRB1 antibody 26455-1-APDownload protocol
WB protocol for CD85j / LILRB1 antibody 26455-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The CD85j / LILRB1 Polyclonal antibody (Cat# 26455-1-AP) has 2 citations. They appear in International Immunopharmacology (2023) and Cancer Medicine (2026). Both studies used IHC on human samples. The research fields cover ovarian cancer immunosuppressive microenvironment and immune cell infiltration, as well as LILRB1 as a prognostic biomarker correlated with immune infiltration in head-and-neck squamous cell carcinoma.

SpeciesApplicationTitle
humanIHC

Int Immunopharmacol

LILRB1+ immune cell infiltration identifies immunosuppressive microenvironment and dismal outcomes of patients with ovarian cancer

Authors - Xiaoyu Xu
humanIHC

Cancer Med

LILRB1 Is a Prognostic-Related Biomarker Correlated With Immune Infiltration in Head-Neck Squamous Cell Carcinoma.

Authors - Shuai Chen
Loading...
||
New chat

Able™

正在加载,请稍候...